MedsFacts Meta-Analysis covering adverse side effect reports of KREMEZIN patients who developed REFLEXES ABNORMAL.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 2 individuals taking KREMEZIN reported REFLEXES ABNORMAL to the FDA. A total of 441 KREMEZIN drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between KREMEZIN and REFLEXES ABNORMAL. In doing so, we compare KREMEZIN with other drugs that cause REFLEXES ABNORMAL, to help you evaluate whether or not KREMEZIN causes REFLEXES ABNORMAL. Likewise, this page shows the most highly-reported side effects of KREMEZIN, so you can see if REFLEXES ABNORMAL ranks among KREMEZIN's most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for KREMEZIN and REFLEXES ABNORMAL, such as the raw number and percentage of patients in FDA reports who used KREMEZIN and developed REFLEXES ABNORMAL. Next, the Dashboard lists the most common reasons (indications) why KREMEZIN was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of KREMEZIN. This pie-chart summarizes, for all FDA reports covering KREMEZIN, whether or not the treating physician felt KREMEZIN (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering KREMEZIN. You may click on any of these side effects to learn more about them, in general, or specifically for KREMEZIN. Finally, we identify the drugs most widely associated with KREMEZIN in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of KREMEZIN causing REFLEXES ABNORMAL: 2
Reports of any side effect of KREMEZIN : 441
Percentage of KREMEZIN patients where REFLEXES ABNORMAL is a reported side effect: 0.45351473922902%
FDA reports of any drug causing REFLEXES ABNORMAL : 276
Average percentage for all medicated patients where REFLEXES ABNORMAL is reported as a complication: 0.0017298050741576%
Most frequent diagnoses/indications for prescribing KREMEZIN:
RENAL FAILURE CHRONIC ( 62 patients )
RENAL FAILURE ( 19 patients )
AZOTAEMIA ( 17 patients )
RENAL IMPAIRMENT ( 9 patients )
PROPHYLAXIS ( 8 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 8 patients )
HYPERTENSION ( 6 patients )
DIABETIC NEPHROPATHY ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 5 patients )
DETOXIFICATION ( 3 patients )
Physician opinion on KREMEZIN as adverse event culprit:
Most common side effects for patients taking KREMEZIN:
BLOOD CREATININE INCREASED (69 patients)
RENAL IMPAIRMENT (51 patients)
BLOOD UREA INCREASED (44 patients)
RENAL FAILURE CHRONIC (37 patients)
RENAL FAILURE (32 patients)
HYPERKALAEMIA (27 patients)
CARDIAC FAILURE (26 patients)
RENAL FAILURE ACUTE (26 patients)
RHABDOMYOLYSIS (25 patients)
NAUSEA (21 patients)
Twitter feed for KREMEZIN - Pending/Beta
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.